rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2010-12-23
|
pubmed:abstractText |
The etiology of Parkinson disease (PD) has yet to be fully elucidated. We examined the consequences of injections of 3,4-dihydroxyphenylacetaldehyde (DOPAL), a toxic metabolite of dopamine, into the substantia nigra of rats on motor behavior and neuronal survival.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e15251
|
pubmed:dateRevised |
2011-7-8
|
pubmed:meshHeading |
pubmed-meshheading:21179455-3,4-Dihydroxyphenylacetic Acid,
pubmed-meshheading:21179455-Animals,
pubmed-meshheading:21179455-Behavior, Animal,
pubmed-meshheading:21179455-Dopamine,
pubmed-meshheading:21179455-Glial Fibrillary Acidic Protein,
pubmed-meshheading:21179455-Immunohistochemistry,
pubmed-meshheading:21179455-Male,
pubmed-meshheading:21179455-Microglia,
pubmed-meshheading:21179455-Neurons,
pubmed-meshheading:21179455-Parkinson Disease,
pubmed-meshheading:21179455-Phenotype,
pubmed-meshheading:21179455-Rats,
pubmed-meshheading:21179455-Rats, Sprague-Dawley,
pubmed-meshheading:21179455-Substantia Nigra,
pubmed-meshheading:21179455-Tyrosine 3-Monooxygenase
|
pubmed:year |
2010
|
pubmed:articleTitle |
The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
|
pubmed:affiliation |
Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America. pannetwm@slu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|